Mac Bonafede

Life Science Research

Mac Bonafede

Mac is a passionate researcher who enjoys collaborating to tackle research questions using real-world data. He is a proponent of team-based problem solving to address a range healthcare research challenges.


Health Economics and Outcomes Research Real World Data / Evidence Value-Based Care

Mac is Vice President of Research Consulting at Veradigm where he leads their team of data scientists, statisticians, and epidemiologists in conducting and guiding real world health economics and outcomes research studies. Mac’s team is adept at using varied real world data sources to generate real world evidence findings in a range of therapeutic areas.

Before joining Veradigm, Dr. Bonafede was with IBM Watson Health (previously Truven Health Analytics and Thomson Reuters Healthcare). Prior to that, Dr. Bonafede served on the faculty of the Albany College of Pharmacy, where he taught courses covering research and statistical methods, total quality management, and evidence-based medicine.

Dr. Bonafede continues to teach in the University of New Hampshire Department of Health Management and Policy’s Masters Degree in Health Data Science. He holds a PhD in health services research and policy and a master’s degree in public health, both from the University of Rochester. Outside of work, Mac is likely to be found working on his family’s 200 year old farmhouse in southern New Hampshire or unsuccessfully trying his hand at small scale agriculture and homesteading.

References to published articles by this expert

  • Thorat, T, McGarry, LJ, Bonafede, MM, et al. Healthcare resource utilization and costs among children with cystic fibrosis in the United States. Pediatric Pulmonology. 2021; 56: 2833- 2844.
  • Bedenbaugh AV, Bonafede M, Marchlewicz EH, Lee V, Tambiah J. Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with Controls. Clinicoecon Outcomes Res. 2021 May 21;13:421-435.
  • Manjelievskaia J, Boytsov N, Brouillette MA, Onyekwere U, Pierce E, Goldblum O, Bonafede M. The direct and indirect costs of adult atopic dermatitis. J Manag Care Spec Pharm. 2021 Oct;27(10):1416-1425.
  • Beyrer J, Manjelievskaia, Bonafede M, Lenhart G, Nolot S, Haldane D, Johnston J. Validation of an International Classification of Disease, 10th Revision Coding Adaptation for the Charlson Comorbidity Index in United States Healthcare Claims Data. Pharmacoepidemiol Drug Saf. 2021 May; 30(5):582-593.
  • Kantor D, Mehta R, Pelletier C, Tian M, Noxon V, Johnson BH, Bonafede M. Treatment Patterns and Relapses Among Newly Treated Multiple Sclerosis Patients From a Retrospective Claims Analysis. Clin Ther. 2020 Nov;42(11):2136-2147.
  • Bonafede M, Mehta R, Kim G, Sruti I, Tian M, Pelletier C, Goldfarb N. Productivity Loss and Associated Costs Among Employed Patients Receiving Disease-Modifying Treatment for Multiple Sclerosis. Pharmacoecon Open. 2021 Mar;5(1):23-34.
  • Schneider DB, Krajcer Z, Bonafede MM, Thoma E, Hasegawa J, Bhounsule P, Thiel E. Clinical and Economic Outcomes of ProGlide Compared to Surgical Repair of Large Bore Arterial Access. J Comp Eff Res. 2019 Dec;8(16): 1381-1392.
  • Bonafede MM, Miller JD, Pohlman SK, Troeger KA, Herschorn SD, Winer IH. Breast, Cervical, and Colorectal Cancer Screening: Patterns among Women with Medicaid and Commercial Insurance. American Journal of Preventive Medicine 2019;57(3):394-402.